A Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary Disease
Completed · Phase 2
Conditions studied: Chronic Obstructive Pulmonary Disease
In brief
The purpose of this study is to evaluate the safety and preliminary performance of the ROX Anastomotic Coupler System (ACS), with standard of care (as defined per GOLD) in patients with Chronic Obstructive Pulmonary Disease (COPD) as compared to standard of care alone.
Key facts
- Study ID
- NCT00992680
- Run by
- ROX Medical, Inc.
- People needed
- 49
- Starts
- 2009-09-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2014-04-21
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of advanced Chronic Obstructive Pulmonary Disease (COPD) must be made on the basis of current findings, medical history and physical examination.
You may not qualify if…
- Subjects not meeting Stage III or IV Chronic Obstructive Pulmonary Disease (COPD)
- Subjects with significant comorbidities
- Subjects not qualifying because of physical or psychological condition that may put them at risk of participating
Where it is running
- Pulmonary Associates — Phoenix, Arizona, United States
- UCLA Medical Center — Los Angeles, California, United States
- Orlando Regional Health Care System — Orlando, Florida, United States
- Sarasota Memorial Hospital — Sarasota, Florida, United States
- Veritas Clinical Specialties, LTD — Topeka, Kansas, United States
- Franklin Square Hospital — Baltimore, Maryland, United States
- Caritas St. Elizabeth's Medical Center — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Oklahoma State University Medical Center — Tulsa, Oklahoma, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.